WallStreetZenWallStreetZen

NASDAQ: LYRA
Lyra Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

LYRA past revenue growth

How has LYRA's revenue growth performed historically?
Company
14.31%
Industry
148.4%
Market
16.96%
LYRA's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
LYRA's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
LYRA's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

LYRA earnings and revenue history

Current Revenue
$1.6M
Current Earnings
-$62.7M
Current Profit Margin
-4,023.1%

LYRA Return on Equity

Current Company
-74.1%
Current Industry
-63.5%
Current Market
188%
LYRA's Return on Equity (-74.1%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when LYRA announces earnings.

LYRA Return on Assets

Current Company
-51.9%
Current Industry
2.9%
LYRA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

LYRA Return on Capital Employed

Current Company
-50.91%
Current Industry
19.5%
LYRA's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

LYRA vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
LYRA$1.56M-$62.34M-$62.68M+4.60%N/A
MGTX$0.00-$57.05M-$84.03MN/AN/A
AVIR$0.00-$134.52M-$135.96M-100.00%N/A
ATAI$314.00k-$35.85M-$40.22M-87.59%N/A
RVNC$234.04M-$290.64M-$323.99M+128.84%N/A
View Top Biotech Stocks

LYRA earnings dates

Next earnings date
May 10, 2024

Lyra Therapeutics Earnings & Revenue FAQ

What were LYRA's earnings last quarter?

On Invalid Date, Lyra Therapeutics (NASDAQ: LYRA) reported Q4 2023 earnings per share (EPS) of -$0.22, up 38.89% year over year. Total Lyra Therapeutics earnings for the quarter were -$15.16 million. In the same quarter last year, Lyra Therapeutics's earnings per share (EPS) was -$0.36.

If you're new to stock investing, here's how to buy Lyra Therapeutics stock.

What was LYRA's earnings growth in the past year?

As of Q2 2024, Lyra Therapeutics's earnings has grown year over year. Lyra Therapeutics's earnings in the past year totalled -$62.68 million.

What is LYRA's earnings date?

Lyra Therapeutics's earnings date is Invalid Date. Add LYRA to your watchlist to be reminded of LYRA's next earnings announcement.

What was LYRA's revenue last quarter?

On Invalid Date, Lyra Therapeutics (NASDAQ: LYRA) reported Q4 2023 revenue of $146.00 thousand up 1,227.27% year over year. In the same quarter last year, Lyra Therapeutics's revenue was $11.00 thousand.

What was LYRA's revenue growth in the past year?

As of Q2 2024, Lyra Therapeutics's revenue has grown 14.31% year over year. This is 134.1 percentage points lower than the US Biotechnology industry revenue growth rate of 148.4%. Lyra Therapeutics's revenue in the past year totalled $1.56 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.